Video

Dr Crystal S. Denlinger Calls for Personalized Care in Cancer Survivorship

Author(s):

As innovations in cancer care transform the disease into a chronic illness, the survivorship population encompasses more than early stage patients but survivors of long term metastatic disease as well, explains Crystal S. Denlinger, MD, Fox Chase Cancer Center in Philadelphia.

As innovations in cancer care transform the disease into a chronic illness, Crystal S. Denlinger, MD, Fox Chase Cancer Center in Philadelphia, says that the survivorship population encompasses more than early stage patients but survivors of long term metastatic disease as well.

Many of the challenges that Dr Denlinger says comes along with cancer survivorship is helping the patient come to terms with the new lifestyle changes that treatment and therapy causes. She adds that patients in different stages of survivorship require different care methods.

“Survivorship care has to be broad enough and as providers, we have to be willing to provide care across those three components of care but with different focuses depending on what stage of disease or what component of survivorship an individual person is living in,”Dr Denlinger says.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Pierluigi Porcu, MD
Benjamin Chen, MD, PhD
Kimberly Westrich, MA, chief strategy officer, NPC
Erin Weber, MS
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Marla Black Morgan, MD, Phoebe Neurology Associates
Elizabeth Grush, MBA
Raj Chovatiya, MD, PhD, MSCI.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo